SCHEMBL9219702

SCHEMBL9219702

Clc1ccc2cc3nc4ccccc4cn3c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 5/20 0.49
HPGD P15428 4/20 0.49
GAA P10253 3/20 0.49
GLA P06280 3/20 0.49
POLB P06746 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP2A6 P11509 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
NR4A2 P43354 1/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
PTPN1 P18031 1/20 0.37
KMT2A Q03164 4/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4501486 0.83 ALDH1A1 (0.41) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL31510889 0.83 ALDH1A1 (0.41) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL30933408 0.73 ALDH1A1 (0.49) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL2850004 0.73 ALDH1A1 (0.49) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL16552253 0.68 ALDH1A1 (0.44) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL17423219 0.66 MAPT (0.65) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL16552320 0.65 KDM4E (0.48) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL29408385 0.64 GAA (0.58) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL7905050 0.63 MAPT (0.65) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL6824253 0.62 CYP2A6 (0.94) KDM4EALDH1A1GAAHSD17B10CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5441955-A Tuberculosis PATHOGENESIS CORPORATION (US) 1995-08-15 US disclosed
WO-1995013807-A1 INDOLO[2,1-b]QUINAZOLINE-6,12-DIONE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF PATHOGENESIS CORPORATION (US) 1995-05-26 WO disclosed